4 min read
Plenary Session Presentation: Putting Science First in Rare Disease Studies
Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...
1 min read
Oncology Expertise to Advance your Compound
Choose Veristat to be your collaborative partner to develop novel cancer therapies and let us provide you with key planning and development guidance. Veristat can guide you through the planning and development process to help you successfully bring a new cancer treatment to market. Our teams will collaborate to design an optimal program, while providing key functional services, including trial design, protocol writing, and statistical consultation with regulatory representation.
Our Goals for Your Program:
Veristat Understands the Oncology Landscape and our Teams work Diligently to:
Trust Veristat to Drive Your Compound’s Success with Complete, Precise, and Timely Regulatory Documents
With 20 years of comprehensive medical writing experience, you can rely on Veristat at any point in the product development lifecycle for complete, precise, and timely support. From a clinical development plan and investigator brochure to your regulatory submission documents, Veristat’s in-house team will complement your efforts. We understand the complexities of the approval process and the importance of presenting accurate and substantial evidence to support the key conclusions of your development program. Working closely with you at every stage, Veristat will custom-build your documents to meet the complex requirements of your product, therapeutic indication, and the applicable regulatory agencies.
4 min read
Mar 22, 2024 Veristat Events
Don´t miss Veristat’s plenary presentation at the World Orphan Drug Congress (WODC), Boston, Thursday, April 25th at...
1 min read
Mar 19, 2024 Veristat Events
Meet Veristat in Basel at the Swiss Biotech Day, 22-23 April 2024
With nearly 30 years of experience in clinical trial...